Vielight Neuro RX Gamma device and irradiation configuration used in the randomized, double-blind, sham-controlled trial. The ...
TORONTO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Vielight Inc., a global leader in brain health technology and photobiomodulation (PBM), proudly announces the launch of the Neuro Pro 2, its most advanced ...
The choice of 810 nm is also supported by photobiology: this wavelength aligns well with the absorption spectrum of cytochrome c oxidase (the mitochondrial “light receptor”) and has been widely used ...
Toronto, Canada, July 26, 2023 (GLOBE NEWSWIRE) -- Vielight Inc. announced it has commenced a new clinical trial in the United States to study how brain stimulation photobiomodulation (PBM) technology ...
Toronto, Ontario, Sept. 02, 2025 (GLOBE NEWSWIRE) -- TORONTO — Aug. 28, 2025 — Vielight , the pioneers of brain photobiomodulation (PBM) neurotechnology, is rapidly emerging as a game-changer for ...
Toronto, Ontario, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Toronto, ON – [ Oct. 1, 2025 ] – Vielight Inc., a global leader in photobiomodulation (PBM) and neuro-stimulation technology, is excited to announce ...